Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction)

American Heart Journal

Volumn 169, Issue 5, 2015, Pages 693-701.e3

  Schroten, Nicolas F ^a   Damman, Kevin ^a   Hemmelder, Marc H ^b   Voors, Adriaan A ^a   Navis, Gerjan ^a   Gaillard, Carlo A J M ^a   Van Veldhuisen, Dirk J ^a   Van Gilst, Wiek H ^a   Hillege, Hans L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; IODOHIPPURATE SODIUM I 131; IOTALAMIC ACID I 125; PLACEBO; AMIDE; FUMARIC ACID DERIVATIVE; RENIN;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANTAGONISTS AND INHIBITORS; BLOOD; BLOOD PRESSURE; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECTS; HEART STROKE VOLUME; KIDNEY CIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AMIDES; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RENAL CIRCULATION; RENIN; RENIN-ANGIOTENSIN SYSTEM; STROKE VOLUME;

EID: 84929290798     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2014.12.016     Document Type: Article

References (28)

1. B. Braam, W.A. Cupples, and J.A. Joles Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure Heart Fail Rev 17 2012 161 175
2. B.F. Palmer Renal dysfunction complicating the treatment of hypertension N Engl J Med 347 2002 1256 1261
3. T.D. Smilde, K. Damman, and P. van der Harst Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure Clin Res Cardiol 98 2009 121 129
4. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
5. W.H. Lee, and M. Packer Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure Circulation 73 1986 257 267
6. K. Swedberg, P. Eneroth, and J. Kjekshus Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group Circulation 82 1990 1730 1736
7. K. Damman, M.A.E. Valente, and A.A. Voors Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta analysis Eur Heart J 35 2014 455 469
8. B. Braam, and H.A. Koomans Renal responses to antagonism of the renin-angiotensin system Curr Opin Nephrol Hypertens 5 1996 89 96
9. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials JAMA 273 1995 1450 1456
10. V.C. Lee, D.C. Rhew, and M. Dylan Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction Ann Intern Med 141 2004 693 704
11. R. Latini, S. Masson, and I. Anand The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 2004 292 299
12. M.K. Szymanski, K. Damman, and D.J. van Veldhuisen Prognostic value of renin and prorenin in heart failure patients with decreased kidney function Am Heart J 162 2011 487 493
13. R.A. de Boer, N.F. Schroten, and S.J. Bakker Plasma renin and outcome in the community: data from PREVEND Eur Heart J 33 2012 2351 2359
14. J.J. McMurray, B. Pitt, and R. Latini Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure Circ Heart Fail 1 2008 17 24
15. A. Seed, R. Gardner, and J. McMurray Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure Eur J Heart Fail 9 2007 1120 1127
16. N.D. Fisher, A.H. Jan Danser, and J. Nussberger Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans Circulation 117 2008 3199 3205
17. T.D. Smilde, D.J. van Veldhuisen, and G. Navis Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 114 2006 1572 1580
18. K. Damman, S. Masson, and H.L. Hillege Clinical outcome of renal tubular damage in chronic heart failure Eur Heart J 32 2011 2705 2712
19. H.H. Parving, B.M. Brenner, and J.J. McMurray Cardiorenal end points in a trial of aliskiren for type 2 diabetes N Engl J Med 367 2012 2204 2213
20. N.K. Hollenberg, N.D. Fisher, and J. Nussberger Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens 29 2011 2454 2461
21. S. Ljungman, J.H. Laragh, and R.J. Cody Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function Drugs 39 1990 10 21 [discussion 22-4]
22. J. Batterink, S.N. Stabler, and A.M. Tejani Spironolactone for hypertension Cochrane Database Syst Rev 8 2010 CD008169 10.1002/14651858.CD008169.pub2
23. J.M. Testani, S.E. Kimmel, and D.L. Dries Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction Circ Heart Fail 4 2011 685 691
24. H.L. Hillege, W.H. van Gilst, and D.J. van Veldhuisen Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial Eur Heart J 24 2003 412 420
25. A. Lesogor, J.N. Cohn, and R. Latini Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study Eur J Heart Fail 15 2013 1236 1244
26. M. Gheorghiade, M. Bohm, and S.J. Greene Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial JAMA 309 2013 1125 1135
27. H.H. Parving, B.M. Brenner, and J.J. McMurray Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol Dial Transplant 24 2009 1663 1671
28. H. Krum, B. Massie, and W.T. Abraham Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study Eur J Heart Fail 13 2011 107 114